Prudential (LON:PRU – Get Rating) had its target price lowered by Deutsche Bank Aktiengesellschaft from GBX 1,550 ($20.17) to GBX 1,475 ($19.19) in a research note issued to investors on Wednesday, Marketbeat reports. The firm currently has a “buy” rating on the financial services provider’s stock. Deutsche Bank Aktiengesellschaft’s price objective suggests a potential upside of 39.81% from the stock’s previous close.
Several other research firms also recently weighed in on PRU. Barclays reissued an “overweight” rating and set a GBX 1,665 ($21.66) price target on shares of Prudential in a research report on Wednesday, April 13th. JPMorgan Chase & Co. set a GBX 1,590 ($20.69) price target on Prudential in a research report on Friday, March 18th. UBS Group set a GBX 1,685 ($21.92) price target on Prudential in a research report on Tuesday, April 12th. Morgan Stanley set a GBX 1,935 ($25.18) price target on Prudential in a research report on Wednesday, April 6th. Finally, Credit Suisse Group set a GBX 1,550 ($20.17) price target on Prudential in a research report on Wednesday, March 30th. Eight investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Prudential presently has an average rating of “Buy” and a consensus price target of GBX 1,695.91 ($22.06).
Prudential stock opened at GBX 1,055 ($13.73) on Wednesday. The company has a debt-to-equity ratio of 41.77, a quick ratio of 0.61 and a current ratio of 1.38. The stock has a fifty day moving average of GBX 1,107.33 and a two-hundred day moving average of GBX 1,267.37. The company has a market capitalization of £29.01 billion and a price-to-earnings ratio of -17.68. Prudential has a fifty-two week low of GBX 976 ($12.70) and a fifty-two week high of GBX 1,598.50 ($20.80).
Prudential Company Profile (Get Rating)
Prudential plc, through its subsidiaries, provides life and health insurance, and retirement and asset management solutions to individuals in Asia, and Africa. It offers health and protection, as well as savings products, such as participating, linked, and other traditional products. The company also provides insurance against common critical illnesses, including cancer, stroke, and heart attack; and tropical disease protection, such as dengue, malaria, and measles.
- 3 Analyst Favorite Blue-Chip Stocks to Buy Now
- Does PNC Financial Stock Belong in Your Portfolio?
- Institutional Buying Puts A Bottom In Manpower Group Inc
- Workhorse Johnson & Johnson Plows New All-Time Highs
- Fastenal Stock is Ready to Sprint Higher
Receive News & Ratings for Prudential Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prudential and related companies with MarketBeat.com's FREE daily email newsletter.